TY  - GEN
AU  - Adlhoch, Cornelia
AU  - Delgado-Sanz, Concepcion
AU  - Carnahan, AnnaSara
AU  - Larrauri, Amparo
AU  - Popovici, Odette
AU  - Bossuyt, Nathalie
AU  - Thomas, Isabelle
AU  - Kynčl, Jan
AU  - Slezák, Pavel
AU  - Brytting, Mia
AU  - Guiomar, Raquel
AU  - Redlberger-Fritz, Monika
AU  - Maistre Melillo, Jackie
AU  - Melillo, Tanya
AU  - van Gageldonk-Lafeber, Arianne B
AU  - Marbus, Sierk D
AU  - O'Donnell, Joan
AU  - Domegan, Lisa
AU  - Gomes Dias, Joana
AU  - Olsen, Sonja J
PY  - 2023
DO  - 10.2807/1560-7917.ES.2023.28.4.2200340
UR  - http://hdl.handle.net/20.500.12105/16485
AB  - Background: Timely treatment with neuraminidase inhibitors (NAI) can reduce severe outcomes in influenza patients. Aim: We assessed the impact of antiviral treatment on in-hospital deaths of laboratory-confirmed influenza patients in 11 European Union...
LA  - eng
PB  - European Centre for Disease Prevention and Control (ECDC)
KW  - EU
KW  - Influenza
KW  - Antiviral treatment
KW  - Clinic
KW  - Epidemiology
KW  - Fatal outcome
KW  - Hospital
KW  - Influenza virus
KW  - Risk factors
KW  - Surveillance
KW  - Oseltamivir
KW  - Influenza, Human
KW  - Humans
KW  - Aged
KW  - Neuraminidase
KW  - Hospital Mortality
KW  - Antiviral Agents
KW  - Enzyme Inhibitors
KW  - Guanidines
KW  - Zanamivir
KW  - Treatment Outcome
TI  - Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020
TY  - research article
ER  -